Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Ohio State University.
Oncol Nurs Forum. 2022 May 1;49(3):213-221. doi: 10.1188/22.ONF.213-221.
To determine oncology providers' experiences and knowledge of opioid use disorders (OUDs) in patients with cancer.
SAMPLE & SETTING: The final sample of 773 participants included 42 physicians, 213 advanced practice providers (APPs), and 518 nurses at a large comprehensive cancer center.
METHODS & VARIABLES: This study used a cross-sectional descriptive survey to describe providers' experiences and knowledge of OUDs.
Nurses and APPs reported personal experiences with addiction and encountering issues with OUDs in patients more often compared to physicians. Knowledge deficits were identified regarding addiction, including evidence-based treatment for OUDs. Overall, OUDs are a topic of concern that the majority of oncology providers are interested in learning more about.
The opioid epidemic presents an opportunity to improve the knowledge of interprofessional oncology providers addressing OUDs. Nurses and APPs are ideally positioned for the prevention and early recognition of patients with an OUD and cancer.
确定肿瘤学提供者在癌症患者中阿片类药物使用障碍(OUD)的经验和知识。
最终样本包括 773 名参与者,其中包括一名大型综合癌症中心的 42 名医生、213 名高级实践提供者(APP)和 518 名护士。
本研究使用横断面描述性调查来描述提供者在 OUD 方面的经验和知识。
护士和 APP 报告说,与医生相比,他们个人有过成瘾经历,并且更经常在患者中遇到 OUD 问题。在成瘾方面存在知识缺陷,包括 OUD 的循证治疗。总体而言,OUD 是一个令人关注的问题,大多数肿瘤学提供者都有兴趣了解更多相关信息。
阿片类药物泛滥为提高解决 OUD 的肿瘤学专业人员的知识提供了机会。护士和 APP 最适合预防和早期识别患有 OUD 和癌症的患者。